Uncategorised - European Medical Journal

ERA 2025: New Biomarker Model Predicts Kidney Fibrosis in IgA Nephropathy

Selected as a top 10 abstract at the ERA Congress, this study unveils a new multiple biomarker model to predict tubulointerstitial fibrosis in IgA nephropathy without a biopsy.

Respiratory Microbiota Shifts with COVID-19 Severity Progression

New research reveals that the composition of the lower respiratory tract microbiota is closely linked to COVID-19 severity.

How Four Botox Options Differ for Frown Lines

The findings highlight that abobotulinum toxin A and prabotulinum toxin A demonstrated the quickest onset of action.

Bradykinin and Angioedema

Angioedema (AE) syndromes are associated with recurrent, unpredictable attacks of subcutaneous and submucosal tissue swelling, which can…

Rheumatoid Arthritis Raises Tuberculosis Risk Despite Screening

In a major new study of over 350,000 individuals, researchers have uncovered compelling evidence that patients with rheumatoid arthritis face a significantly higher risk of developing active pulmonary tuberculosis, even in modern healthcare settings where tuberculosis screening precedes biologic treatment.

GSK’s Dheepa Chari on the evolving sphere of scientific communication

Dheepa Chari joins EMJ GOLD to discuss her career path, AI in pharma and the future of scientific communication.

Laser Dermatology in the US: Are Patients Sacrificing Safety for Speed?

A new study reveals major differences in cosmetic laser practices across US dermatologists, plastic surgeons, and medical spas. Key findings raise patient safety concerns and emphasize the importance of specialized training.

Transforming the Cath Lab: Interview with Arnold Seto

Transforming the Cath Lab: Interview with Arnold Seto Division of Cardiology, Long Beach Veterans Administration Healthcare System…

Vantive to invest $1bn in digital kidney care therapies

Vantive has announced the five-year, major investment to expand its R&D and manufacturing capabilities.

Treatment Outcomes in High-Grade NMIBC Compared

Discover a study that found that 22% of patients who underwent radical cystectomy were upstaged at surgery, leading to a lower 12-month progression-free survival rate.